Interestingly, all RET+ patients had a small primary lesion (<3 cm) with a significantly higher percentage of N2 disease (54.5% for RET+ vs. 22.6% for other adenocarcinoma patients, p = 0.024) [12]. This evidence concerns the gene RET and adenocarcinoma.